Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Craig-Hallum raised the firm’s price target on CVRx (CVRX) to $22 from $20 and keeps a Buy rating on the shares. CVRx posted a modest beat in ...

Craig-Hallum raised the price target on CVRx Inc (NASDAQ:CVRX) shares to $22.00 from $20.00, maintaining a Buy rating on the company's shares. The adjustment came after CVRx reported a modest beat in ...

William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...

In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on CVRx (CVRX – Research Report). The company’s ...

Fourth quarter revenue expected to be $15.2 million to $15.3 million, representing growth of 35%Full year revenue expected to ...

CVRx anticipates a 35% increase in Q4 2024 revenue and a 30% increase in FY24 revenue, with shares down 1.55% premarket.

MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43 rd ...

CVRx (NASDAQ:CVRX) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of ...

NASDAQ:CVRX opened at $13.64 on Monday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 10.23 and a current ratio of 11.32. The company has a market capitalization of $330.91 ...